<DOC>
	<DOCNO>NCT01878604</DOCNO>
	<brief_summary>Identify new novel gene may impact cholesterol level , establish relationship gene mutation atherosclerosis , well responses lipid-lowering drug .</brief_summary>
	<brief_title>Gene Analysis Treatment Optimization Chinese Homozygous Familial Hypercholesterolemia</brief_title>
	<detailed_description>To good understand genetics basis LDL-C elevation develop optimized lipid-lowering strategy , propose follow study : 1 . To establish China HoFH registry , collect DNA blood sample available family member proband ( pedigree ) ; 2 . To detect gene mutation know cause FH identify family suitable future whole genome sequencing aim identify novel gene control cholesterol level . 3.To establish relationship type gene mutation lipid atherosclerosis profile , well responses lipid-lowering agent .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type II</mesh_term>
	<mesh_term>Hypolipidemic Agents</mesh_term>
	<criteria>Inclusion criterion : Patients age sex meet clinical genetic criterion hoFH follow : Cutaneous xanthomata age ten year LDLC &gt; 13 mmol/L treatment &gt; 7.76 mmol/L despite treatment Phenotypic feature keep HeFH parent Exclusion criterion : Inability patient , , less 18 , parent , sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>